Summary: An enzyme enhanced luminescence immunoassay has been developed using the determination of serum transferrin äs a model. The assay has been compared with an established radioimmunoassay, the details of which have already been published (Wood, W. G. et al. (1980) Fresenius Z. Anal. Chem. 301,120). After comparison, the luminescence immunoassay was introduced äs the routine method for determining transferrin levels in human serum.
Introduction
This type of assay is not äs susceptible to quench effects often seen in chemiluminescence immunoassays (2) (3) (4) This article describes an alternative to radioimmunomakin ß * P°s sible to measure serum P roteins and hor -• assay using a combination of enzyrüe and luminescence mones. techniques which form the basis of the enzyme enhanced The principle of the test is a combination of an enzymeluininescenee immunoassay. The choice of transferrin äs labelled antigen using pyruvate kinase (EC 2.7.1.40) Parameter was twofold, namely to reduce the need for a coupled to an ATP dependent luciferin-luciferase sysradioactive tracer, which had to be produced in the tem. The rate of ATP formation from ADP and phoslaboratory, and to set up a robust assay System which phoenol pyruvate is proportional to the light intensity would work under routine conditions. At this stage, the and inversely proportional to the concentration of nondetection lirnits of the System were of secondary iinporlabelled antigen in the System when the antibody-bound tance.
fraction is measured, Preparation ofthe pyruvate kinase labetted transferrin l ml human transferrin solution (l μπιοί) was coupled to 70 μ\ (1.2 μπιοί) tfz-maleimidobenzoyl-N-hydroxy-succinimide ester at pH 7.0 in 0.1 mol/1 phosphate buffer using the method viKitgawa (5) . After coupling, the mixture was dialysed against 0.1 mol/1 phosphate buffer, pH 7.0 to remove unreacted w-maleimidobenzoyl-N-hydroxy-succinimide ester and tetrahydrofurane. 25 nmol pyruvate kinase was added to the transferrin-m-maleimidobenzoyl-N-hydroxy-succinimide and aUpwed to react for 30 min at ambient temperature, followed by 18 h at 4 °C. The product so formed was separated on an Ultrogel A6 column (60 X 2 cm) using 0.02 mol/1 phosphate buffer containing 0.1 mol · liter' 1 NaCl, pH 7.0. The fractions (2 ml) were collected and tested for pyruvate kinase activity and for immunoreactive transferrin, after a prior dilution of 1:500. The fractions containing pyruvate kinase activity and transferrin were pooled, lyophilised and stored at 4 °C until use.
Preparation of solid-phase second antibody 20 g microcrystalline cellulose (Sigma) were suspended in 100 ml 0.05 mol/1 borate buffer, pH 6.0 and 100 mg NaI 4 added. The mixture was stirred and jcept at 70 °C for 2 hours. The presence of aldehyde groups was monitored using Schiffs reagent (p-rosaniline saturated with 802). The oxidation of the vicinal hydroxylgroups of the cellulose matrix was seen by an increasing violet coloration of the mixture. The reaction was completed after ca. 90 minutes. The microcrystalline cellulose was centrifuged, the supernatant removed and the precipitate washed twice with distiUed water. The precipitate was then resuspended in 200 ml 0.05 mol/1 Na 2 B 4 O 7 , pH 9.35 and 100 mg -y-globulin fraction of the second antibody (donkey-anti rabbit IgG) added. The mixture was stirred for 24 hours at 4 °C after which it was tested for free aldehyde groups s above. If the reaction was positive, ethanolamine (l mol/1, pH 9.35) was added until the Schiff-iezction remained negative. The slurry was then washed s above, fmally being suspended in 200 ml H 3 BO 3 (0.05 mol/1, pH 5.2) and 200 mg NaBH 4 added to stabilise the Schiff bases formed during the coupling. The mixture was stirred for 30 min at ambient temperature, being then washed s above, fmally being suspended in 100 ml 0.05 mol/1 phosphate buffer, pH 7.5 containing bovine serum albumin (5 g · liter" 1 ) to saturate any active sites. Before use in the assay the slurry was further diluted 1:10 with potassium phosphate buffer (0.05 mol/1, pH 7.8).
Enzyme enhanced luminescence and radioimmunoassays for transferrin
The radioimmunoassay was performed s already published (1) with the following changes: The serum samples were diluted l: 100 before assay and the Separation of bound and free antigen was carried out using the solid phase second antibody described above. The luminescence immunoassay was carried out identically with the radioimmunoassay with the exception ofthe tracer. The assay s are summarised below: 20 μΐ serum or Standard (diluted 1:100 in 0,15 mol/l NaCl containing EDTA (0.01 mol/1) The radioimmunoassay was then counted in a multi-channel gamma counter (Nuclear Enterprises Type NE 1600) for l mfav· ute, the data processing being carried out online with a GBM 4032 desk top Computer using a spline function (6) with an adapted Programme described by Marschner et al. (7), in which an autoiiiatic smoothing routine had been incprporated. The luminescence immunoassay precipitates were treated s follows after the KG wash sequence: 400 μΐ Tris-Hd buffer (0.1 mol/U pH 7.8) containing EDTA (0.01 mol/1) and 200 μΐ of a mixture of ADP, ph sphoenol pyruvate (both 0.1 mmol/1) and ATP-monitoring reagent (1+1+2 by Volume) were added to the precipitate and the ATP production monitored in the luminometer with pl tter trace and 10 second integral print-outs. The rate of ATP production was expressed s mV · s" 1 . The reaction was followed from the 31 st to the 60th secorids pver 3 successive 10 second periods, the mean mV change for each period calculated, checked for linearity and the mean value used for data processing.
Results

Constancy ofA TP production
In a series of 1000 measurements, the Variation ofthe slope dV/dt was under l % in each case for the time interval 31-60 seconds for the 3 suecessive time intervals of 10 seconds, i. e. the slope was fully linear during the period of measurenient.
Intra-and intef-ass y coefficients of Variation
The intra-assay coefficient of Variation (CV)measured at three points along the Standard cufve was s follows: Test serum 1: mean 4.08 g -liter" The inter-assay CV for the same control sera was s follows: Test serum l: mean 3.58 g -liter" The inter-assay CV was deterrnined from tue mean of duplicate values frorri each assay.
Correlation ofthe enzyme enhanced luminescence immunoassay with the radioimmunoassay
The correlation between the luminescence-and radioimmunoassays was made from data from 14 assays carried out siniultaneously for both methods. The only difference in the assays was the tracer. Values from the radioimmunoassay were entered äs x, those from the luminescence immunoassay äs y. 147 serum samples were used in the comparison.
The regression line y = a + bx had the following coefficients: a = 0.01, b =1.05, with a correlation coefficient of r = 0.960. The mean value for the radioimmunoassay was 2.13g-liter' 1 (ränge 0.11-7.58 g · liter" 1 ) and for the luminescence immunoassay 2.24 g · liter" 1 , (ränge 0.10-7.34 g-liter"
1 ).
The reference ränge for both assays was the same, i.e. 2-4 g · liter"
1 , for persons with normal body iron Status äs determined for this laboratory (8) .
Standard curve data
The data from two typical Standard curves is shown in table l. It can be seen that the form of the luminescence and radioimmunoassay Standard curves are similar. The data is expressed in tabular form to allow a better comparison of the data received. 
Recovery studies on the enzyme enhanced luminescence immunoassay
Human transferrin was added to two sera with known endogenöus transferrin levels (determined äs the mean values from duplicate determinations in 20 assays in the radioimmunoassay). One serum was from a patient on haemodialysis, with diminished transferrin, the other was a patient with normal body iron Status (haemoglobin 149 g · liter" 1 , Hb E 32 pg, serum ferritin 102 % -liter" 1 (8) 
Discussion
This article describes an alternative to radioimmunoassay for the determination of proteins in biological fluids. The System chosen with transferrin äs analyte was not meant to test the potential sensitivity of the method, but rather to establish a routine assay robust enough to be carried out*y all laboratory personnel. The assays correlate well with each other, the reference ränge not having to be changed when the luminescence immunoassay replaced the radioimmunoassay for the routine determination of serum transferrin.
Preliminary data (Fricke -unpublished data 1981) has shown that the pyruvate kinase labelled antigen coupled with the firefly luciferin-luciferase System is sensitive enough to measure insulin levels in untreated sera with an assay sensitivity of under 5 mU/1, using an analogous assay System to the one here described. The advantage of the System used here, over conventional chemiluminescence immunoassays is that the quenching effect due to proteins is absent. This is due to the fact that the light-generation System is independent of the antigenantibody binding site.
The use of a solid-phase second antibody Separation step allows the removäl of potential interference from serum components. The use of microcrystalline cellulose äs support, paradox though it may seem, does not appear to affect the linearity of the light Output, although for the rnore sensitive assays, the volume ofthe second antibody must be reduced to keep potential light absorp-tion to a minimum. This can be done by increasing the amount of second antibody per unit mass of support, or by substituting the cellulose for a more translucent material, for example activated polymer beads.
Although this assay has been built up using pyruvate kinase äs label, other enzymes with lower molecular weight appear to be better for hapten assays, for example myokinase (EC 2.7.4.3). One is not limited to the ADP-ATP System coupled to firefly luciferin-luciferase, and other enzymes with high turnover rates, for example glucose-6-phosphate dehydrogenase (EC 1.1.1.49) can be used coupled to an NADP-NADPH dependant bacterial luciferin luciferase System.
The main problem of introducing such assays is the problem of automation. One must compare the present state of luminescence detection Systems currently available with the availability of automatic gamma-counters in the early 1960s. At the present time, there is only one automatic luminorneter available (LKB 1251) which can sample 25 tu ! bes sequentially.
The future of luminescence immunoassay lies in the availability of kits and süitable monitoring equipment, äs before this, there is little iiicentive to change from radioimmunoassays to these alternative techrjdques.
